Buprenorphine now replaces methadone as the most common medicine for opioid dependence’: 10-year trends in opioid agonist treatment medicines in Australia
National Drug & Alcohol Research Centre Blog
DECEMBER 4, 2023
We converted information on monthly sales of methadone, sublingual buprenorphine (+/- naloxone) and buprenorphine between 2013 and 2022 into an estimate of the number of clients receiving these medicines each month, based on average doses in Australia (“client-months”). Chidwick, K., Farrell, M., & Degenhardt, L. Vol 123, p.
Let's personalize your content